nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—dermis—systemic scleroderma	0.0777	0.284	CbGeAlD
Pentosan Polysulfate—FGF4—connective tissue—systemic scleroderma	0.0424	0.155	CbGeAlD
Pentosan Polysulfate—FGF1—artery—systemic scleroderma	0.0281	0.103	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—systemic scleroderma	0.0237	0.0867	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—systemic scleroderma	0.0219	0.08	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—systemic scleroderma	0.0138	0.0504	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—systemic scleroderma	0.0112	0.041	CbGeAlD
Pentosan Polysulfate—FGF4—Differentiation Pathway—CSF1—systemic scleroderma	0.0105	0.0532	CbGpPWpGaD
Pentosan Polysulfate—FGF2—tendon—systemic scleroderma	0.0104	0.0379	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—systemic scleroderma	0.0103	0.0375	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—systemic scleroderma	0.0101	0.037	CbGeAlD
Pentosan Polysulfate—FGF2—lung—systemic scleroderma	0.0091	0.0333	CbGeAlD
Pentosan Polysulfate—FGF1—digestive system—systemic scleroderma	0.0081	0.0296	CbGeAlD
Pentosan Polysulfate—FGF2—Glypican 1 network—BLK—systemic scleroderma	0.0076	0.0386	CbGpPWpGaD
Pentosan Polysulfate—FGF1—lung—systemic scleroderma	0.00676	0.0247	CbGeAlD
Pentosan Polysulfate—FGF1—Differentiation Pathway—CSF1—systemic scleroderma	0.00665	0.0338	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Non-integrin membrane-ECM interactions—HSPG2—systemic scleroderma	0.00616	0.0313	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Differentiation Pathway—CSF1—systemic scleroderma	0.00607	0.0308	CbGpPWpGaD
Pentosan Polysulfate—FGF4—GAB1 signalosome—CSK—systemic scleroderma	0.00505	0.0257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrins in angiogenesis—CSF1—systemic scleroderma	0.00488	0.0248	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrins in angiogenesis—COL1A2—systemic scleroderma	0.00445	0.0226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00373	0.019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Neural Crest Differentiation—RHOB—systemic scleroderma	0.00324	0.0164	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—CSK—systemic scleroderma	0.00322	0.0164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—GAB1 signalosome—CSK—systemic scleroderma	0.00321	0.0163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00319	0.0162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiogenesis—NOS3—systemic scleroderma	0.00318	0.0161	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00309	0.0157	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—CSK—systemic scleroderma	0.00293	0.0149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00282	0.0143	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—BLK—systemic scleroderma	0.00262	0.0133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiogenesis—MMP9—systemic scleroderma	0.00255	0.013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Syndecan interactions—TGFB1—systemic scleroderma	0.00243	0.0124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00237	0.012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.00224	0.0114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00216	0.011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Differentiation Pathway—TGFB1—systemic scleroderma	0.00209	0.0106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—CSK—systemic scleroderma	0.00205	0.0104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00203	0.0103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Syndecan-4-mediated signaling events—MMP9—systemic scleroderma	0.00203	0.0103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—FBN1—systemic scleroderma	0.00202	0.0103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Glypican 1 network—TGFB1—systemic scleroderma	0.00197	0.01	CbGpPWpGaD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00192	0.00973	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.00189	0.0096	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.00189	0.00958	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—CSK—systemic scleroderma	0.00187	0.00947	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—CSK—systemic scleroderma	0.00185	0.00939	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.00177	0.00898	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	0.00168	0.00854	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—BLK—systemic scleroderma	0.00166	0.00844	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—BLK—systemic scleroderma	0.00152	0.0077	CbGpPWpGaD
Pentosan Polysulfate—FGF1—FGF signaling pathway—MMP9—systemic scleroderma	0.00146	0.00743	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—HSPG2—systemic scleroderma	0.00142	0.00719	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—COL1A2—systemic scleroderma	0.00142	0.00719	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Non-integrin membrane-ECM interactions—TGFB1—systemic scleroderma	0.00134	0.00682	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Differentiation Pathway—TGFB1—systemic scleroderma	0.00132	0.00673	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—ITGAM—systemic scleroderma	0.00129	0.00653	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CSK—systemic scleroderma	0.00121	0.00616	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Differentiation Pathway—TGFB1—systemic scleroderma	0.00121	0.00613	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—ITGAM—systemic scleroderma	0.00119	0.00603	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CD247—systemic scleroderma	0.00119	0.00603	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—MMP9—systemic scleroderma	0.00116	0.00591	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD247—systemic scleroderma	0.00114	0.00579	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Cardiac Progenitor Differentiation—TGFB1—systemic scleroderma	0.00112	0.00567	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—TNFAIP3—systemic scleroderma	0.00111	0.00565	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00108	0.0055	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.00107	0.00543	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—BLK—systemic scleroderma	0.00106	0.00536	CbGpPWpGaD
Pentosan Polysulfate—Agitation—Mycophenolic acid—systemic scleroderma	0.00101	0.0019	CcSEcCtD
Pentosan Polysulfate—Alopecia—Lisinopril—systemic scleroderma	0.001	0.00189	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Captopril—systemic scleroderma	0.001	0.00189	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.000997	0.00188	CcSEcCtD
Pentosan Polysulfate—Dizziness—Pentoxifylline—systemic scleroderma	0.000993	0.00188	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Captopril—systemic scleroderma	0.00099	0.00187	CcSEcCtD
Pentosan Polysulfate—Malaise—Mycophenolic acid—systemic scleroderma	0.000989	0.00187	CcSEcCtD
Pentosan Polysulfate—Infection—Azathioprine—systemic scleroderma	0.000987	0.00186	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000987	0.00186	CcSEcCtD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000985	0.005	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000982	0.00185	CcSEcCtD
Pentosan Polysulfate—Myalgia—Leflunomide—systemic scleroderma	0.000979	0.00185	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Leflunomide—systemic scleroderma	0.000979	0.00185	CcSEcCtD
Pentosan Polysulfate—Constipation—Captopril—systemic scleroderma	0.000973	0.00184	CcSEcCtD
Pentosan Polysulfate—Flatulence—Lisinopril—systemic scleroderma	0.000973	0.00184	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000973	0.00184	CcSEcCtD
Pentosan Polysulfate—Discomfort—Leflunomide—systemic scleroderma	0.000967	0.00183	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—SMAD7—systemic scleroderma	0.000964	0.0049	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—TGFB1—systemic scleroderma	0.000959	0.00487	CbGpPWpGaD
Pentosan Polysulfate—Affect lability—Prednisone—systemic scleroderma	0.000959	0.00181	CcSEcCtD
Pentosan Polysulfate—Vomiting—Pentoxifylline—systemic scleroderma	0.000955	0.0018	CcSEcCtD
Pentosan Polysulfate—Rash—Pentoxifylline—systemic scleroderma	0.000947	0.00179	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000946	0.00179	CcSEcCtD
Pentosan Polysulfate—Headache—Pentoxifylline—systemic scleroderma	0.000941	0.00178	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Captopril—systemic scleroderma	0.000938	0.00177	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000934	0.00176	CcSEcCtD
Pentosan Polysulfate—Myalgia—Mycophenolic acid—systemic scleroderma	0.000934	0.00176	CcSEcCtD
Pentosan Polysulfate—Infection—Leflunomide—systemic scleroderma	0.000932	0.00176	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Captopril—systemic scleroderma	0.000931	0.00176	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Methotrexate—systemic scleroderma	0.000927	0.00175	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000927	0.00175	CcSEcCtD
Pentosan Polysulfate—Mood swings—Prednisone—systemic scleroderma	0.000923	0.00174	CcSEcCtD
Pentosan Polysulfate—Discomfort—Mycophenolic acid—systemic scleroderma	0.000922	0.00174	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000919	0.00173	CcSEcCtD
Pentosan Polysulfate—Pruritus—Mometasone—systemic scleroderma	0.000917	0.00173	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000916	0.00173	CcSEcCtD
Pentosan Polysulfate—Anaemia—Lisinopril—systemic scleroderma	0.000913	0.00172	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—RHOB—systemic scleroderma	0.000909	0.00462	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000907	0.00171	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000905	0.00171	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Captopril—systemic scleroderma	0.0009	0.0017	CcSEcCtD
Pentosan Polysulfate—Oedema—Mycophenolic acid—systemic scleroderma	0.000895	0.00169	CcSEcCtD
Pentosan Polysulfate—Anorexia—Leflunomide—systemic scleroderma	0.000894	0.00169	CcSEcCtD
Pentosan Polysulfate—Nausea—Pentoxifylline—systemic scleroderma	0.000892	0.00168	CcSEcCtD
Pentosan Polysulfate—Malaise—Lisinopril—systemic scleroderma	0.000891	0.00168	CcSEcCtD
Pentosan Polysulfate—Infection—Mycophenolic acid—systemic scleroderma	0.000889	0.00168	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mometasone—systemic scleroderma	0.000887	0.00167	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Lisinopril—systemic scleroderma	0.000884	0.00167	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—TGFBI—systemic scleroderma	0.000882	0.00448	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000878	0.00166	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000876	0.00165	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000865	0.00163	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CTLA4—systemic scleroderma	0.000865	0.00439	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000855	0.00161	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000853	0.00161	CcSEcCtD
Pentosan Polysulfate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000853	0.00161	CcSEcCtD
Pentosan Polysulfate—Insomnia—Leflunomide—systemic scleroderma	0.000849	0.0016	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Leflunomide—systemic scleroderma	0.000842	0.00159	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Lisinopril—systemic scleroderma	0.000841	0.00159	CcSEcCtD
Pentosan Polysulfate—Myalgia—Lisinopril—systemic scleroderma	0.000841	0.00159	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Leflunomide—systemic scleroderma	0.000836	0.00158	CcSEcCtD
Pentosan Polysulfate—Discomfort—Lisinopril—systemic scleroderma	0.000831	0.00157	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Leflunomide—systemic scleroderma	0.000826	0.00156	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mometasone—systemic scleroderma	0.000824	0.00156	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Prednisone—systemic scleroderma	0.00082	0.00155	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Azathioprine—systemic scleroderma	0.000819	0.00155	CcSEcCtD
Pentosan Polysulfate—Rash—Mometasone—systemic scleroderma	0.000817	0.00154	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mometasone—systemic scleroderma	0.000816	0.00154	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Leflunomide—systemic scleroderma	0.000816	0.00154	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000815	0.00154	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000812	0.00153	CcSEcCtD
Pentosan Polysulfate—Headache—Mometasone—systemic scleroderma	0.000812	0.00153	CcSEcCtD
Pentosan Polysulfate—Insomnia—Mycophenolic acid—systemic scleroderma	0.000809	0.00153	CcSEcCtD
Pentosan Polysulfate—Oedema—Lisinopril—systemic scleroderma	0.000806	0.00152	CcSEcCtD
Pentosan Polysulfate—Pruritus—Captopril—systemic scleroderma	0.000805	0.00152	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000804	0.00152	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00152	CcSEcCtD
Pentosan Polysulfate—Constipation—Leflunomide—systemic scleroderma	0.000802	0.00151	CcSEcCtD
Pentosan Polysulfate—Infection—Lisinopril—systemic scleroderma	0.000801	0.00151	CcSEcCtD
Pentosan Polysulfate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00151	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000798	0.00151	CcSEcCtD
Pentosan Polysulfate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000795	0.0015	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000789	0.00149	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000788	0.00149	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Azathioprine—systemic scleroderma	0.000785	0.00148	CcSEcCtD
Pentosan Polysulfate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00147	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000779	0.00147	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Captopril—systemic scleroderma	0.000779	0.00147	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000778	0.00147	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00146	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000773	0.00146	CcSEcCtD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000772	0.00392	CbGpPWpGaD
Pentosan Polysulfate—Mood swings—Methotrexate—systemic scleroderma	0.000771	0.00146	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CSK—systemic scleroderma	0.00077	0.00391	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Mometasone—systemic scleroderma	0.00077	0.00145	CcSEcCtD
Pentosan Polysulfate—Anorexia—Lisinopril—systemic scleroderma	0.000768	0.00145	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000767	0.00145	CcSEcCtD
Pentosan Polysulfate—Weight increased—Prednisone—systemic scleroderma	0.000766	0.00145	CcSEcCtD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000766	0.00389	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Mycophenolic acid—systemic scleroderma	0.000765	0.00145	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Prednisone—systemic scleroderma	0.000762	0.00144	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—ITGAM—systemic scleroderma	0.000754	0.00383	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CD247—systemic scleroderma	0.000754	0.00383	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Captopril—systemic scleroderma	0.000753	0.00142	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000752	0.00142	CcSEcCtD
Pentosan Polysulfate—Depression—Prednisone—systemic scleroderma	0.000749	0.00141	CcSEcCtD
Pentosan Polysulfate—Urticaria—Leflunomide—systemic scleroderma	0.000745	0.00141	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Leflunomide—systemic scleroderma	0.000742	0.0014	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000738	0.00139	CcSEcCtD
Pentosan Polysulfate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000737	0.00139	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000737	0.00139	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CSK—systemic scleroderma	0.000736	0.00374	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000734	0.00139	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000732	0.00138	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000732	0.00138	CcSEcCtD
Pentosan Polysulfate—Insomnia—Lisinopril—systemic scleroderma	0.000729	0.00138	CcSEcCtD
Pentosan Polysulfate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00137	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD247—systemic scleroderma	0.000724	0.00368	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IRF5—systemic scleroderma	0.000724	0.00368	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Lisinopril—systemic scleroderma	0.000724	0.00137	CcSEcCtD
Pentosan Polysulfate—Vomiting—Captopril—systemic scleroderma	0.000724	0.00137	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Lisinopril—systemic scleroderma	0.000719	0.00136	CcSEcCtD
Pentosan Polysulfate—Rash—Captopril—systemic scleroderma	0.000718	0.00136	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Captopril—systemic scleroderma	0.000717	0.00135	CcSEcCtD
Pentosan Polysulfate—Headache—Captopril—systemic scleroderma	0.000713	0.00135	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000712	0.00362	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Lisinopril—systemic scleroderma	0.00071	0.00134	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000707	0.00134	CcSEcCtD
Pentosan Polysulfate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00133	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000706	0.00359	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HSPG2—systemic scleroderma	0.000704	0.00357	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CSK—systemic scleroderma	0.000702	0.00357	CbGpPWpGaD
Pentosan Polysulfate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00132	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Lisinopril—systemic scleroderma	0.000701	0.00132	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—IRF8—systemic scleroderma	0.000692	0.00351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD247—systemic scleroderma	0.000692	0.00351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ITGAM—systemic scleroderma	0.000692	0.00351	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000692	0.00131	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000691	0.00131	CcSEcCtD
Pentosan Polysulfate—Constipation—Lisinopril—systemic scleroderma	0.000689	0.0013	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—ITGAM—systemic scleroderma	0.000688	0.00349	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CD247—systemic scleroderma	0.000688	0.00349	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000683	0.00129	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Azathioprine—systemic scleroderma	0.00068	0.00128	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—CSK—systemic scleroderma	0.000679	0.00345	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.000679	0.00345	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Captopril—systemic scleroderma	0.000676	0.00128	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—SMAD7—systemic scleroderma	0.000675	0.00343	CbGpPWpGaD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000675	0.00127	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000673	0.00127	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD40LG—systemic scleroderma	0.000672	0.00341	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—BLK—systemic scleroderma	0.00067	0.0034	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000664	0.00125	CcSEcCtD
Pentosan Polysulfate—Pruritus—Leflunomide—systemic scleroderma	0.000664	0.00125	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD247—systemic scleroderma	0.00066	0.00335	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000659	0.00124	CcSEcCtD
Pentosan Polysulfate—Dizziness—Azathioprine—systemic scleroderma	0.000657	0.00124	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—TNFAIP3—systemic scleroderma	0.000648	0.00329	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP1—systemic scleroderma	0.000644	0.00327	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TNFAIP3—systemic scleroderma	0.000644	0.00327	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000643	0.00122	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000642	0.00121	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Leflunomide—systemic scleroderma	0.000642	0.00121	CcSEcCtD
Pentosan Polysulfate—Urticaria—Lisinopril—systemic scleroderma	0.00064	0.00121	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—BLK—systemic scleroderma	0.00064	0.00325	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CD247—systemic scleroderma	0.000639	0.00324	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00121	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Lisinopril—systemic scleroderma	0.000637	0.0012	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000634	0.0012	CcSEcCtD
Pentosan Polysulfate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000633	0.0012	CcSEcCtD
Pentosan Polysulfate—Vomiting—Azathioprine—systemic scleroderma	0.000632	0.00119	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00063	0.00119	CcSEcCtD
Pentosan Polysulfate—Rash—Azathioprine—systemic scleroderma	0.000626	0.00118	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Azathioprine—systemic scleroderma	0.000626	0.00118	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—systemic scleroderma	0.000626	0.00118	CcSEcCtD
Pentosan Polysulfate—Headache—Azathioprine—systemic scleroderma	0.000622	0.00118	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000622	0.00117	CcSEcCtD
Pentosan Polysulfate—Dizziness—Leflunomide—systemic scleroderma	0.00062	0.00117	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MMP9—systemic scleroderma	0.000619	0.00314	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00116	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000612	0.00116	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—SMAD7—systemic scleroderma	0.000612	0.00311	CbGpPWpGaD
Pentosan Polysulfate—Stomatitis—Methotrexate—systemic scleroderma	0.000612	0.00115	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—BLK—systemic scleroderma	0.000611	0.0031	CbGpPWpGaD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—systemic scleroderma	0.00061	0.00115	CcSEcCtD
Pentosan Polysulfate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000604	0.00114	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—systemic scleroderma	0.000601	0.00114	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—systemic scleroderma	0.000598	0.00113	CcSEcCtD
Pentosan Polysulfate—Vomiting—Leflunomide—systemic scleroderma	0.000596	0.00113	CcSEcCtD
Pentosan Polysulfate—Alopecia—Prednisone—systemic scleroderma	0.000595	0.00112	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000594	0.00112	CcSEcCtD
Pentosan Polysulfate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000592	0.00112	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—systemic scleroderma	0.000592	0.00112	CcSEcCtD
Pentosan Polysulfate—Rash—Leflunomide—systemic scleroderma	0.000592	0.00112	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Leflunomide—systemic scleroderma	0.000591	0.00112	CcSEcCtD
Pentosan Polysulfate—Nausea—Azathioprine—systemic scleroderma	0.00059	0.00111	CcSEcCtD
Pentosan Polysulfate—Headache—Leflunomide—systemic scleroderma	0.000588	0.00111	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000582	0.0011	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000578	0.00109	CcSEcCtD
Pentosan Polysulfate—Pruritus—Lisinopril—systemic scleroderma	0.00057	0.00108	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000569	0.00107	CcSEcCtD
Pentosan Polysulfate—Rash—Mycophenolic acid—systemic scleroderma	0.000564	0.00107	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000564	0.00106	CcSEcCtD
Pentosan Polysulfate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000561	0.00106	CcSEcCtD
Pentosan Polysulfate—Headache—Mycophenolic acid—systemic scleroderma	0.000561	0.00106	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—TGFBI—systemic scleroderma	0.00056	0.00284	CbGpPWpGaD
Pentosan Polysulfate—Pharyngitis—Methotrexate—systemic scleroderma	0.000559	0.00106	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000558	0.00105	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—SMAD7—systemic scleroderma	0.000558	0.00284	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Leflunomide—systemic scleroderma	0.000557	0.00105	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Lisinopril—systemic scleroderma	0.000552	0.00104	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CTLA4—systemic scleroderma	0.000549	0.00279	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000544	0.00103	CcSEcCtD
Pentosan Polysulfate—Anaemia—Prednisone—systemic scleroderma	0.000542	0.00102	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—systemic scleroderma	0.000539	0.00102	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lisinopril—systemic scleroderma	0.000533	0.00101	CcSEcCtD
Pentosan Polysulfate—Nausea—Mycophenolic acid—systemic scleroderma	0.000532	0.001	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisone—systemic scleroderma	0.000529	0.000999	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—systemic scleroderma	0.000525	0.000992	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CTLA4—systemic scleroderma	0.000524	0.00266	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RHOB—systemic scleroderma	0.000522	0.00265	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00052	0.000983	CcSEcCtD
Pentosan Polysulfate—Vomiting—Lisinopril—systemic scleroderma	0.000513	0.000968	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—TGFBI—systemic scleroderma	0.000511	0.00259	CbGpPWpGaD
Pentosan Polysulfate—Rash—Lisinopril—systemic scleroderma	0.000508	0.00096	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lisinopril—systemic scleroderma	0.000508	0.000959	CcSEcCtD
Pentosan Polysulfate—Headache—Lisinopril—systemic scleroderma	0.000505	0.000954	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CTLA4—systemic scleroderma	0.0005	0.00254	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0005	0.000944	CcSEcCtD
Pentosan Polysulfate—Myalgia—Prednisone—systemic scleroderma	0.000499	0.000943	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—systemic scleroderma	0.000499	0.000943	CcSEcCtD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP2—systemic scleroderma	0.000498	0.00253	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Methotrexate—systemic scleroderma	0.000498	0.00094	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—systemic scleroderma	0.000493	0.000932	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—HSPG2—systemic scleroderma	0.000493	0.0025	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000913	CcSEcCtD
Pentosan Polysulfate—Nausea—Lisinopril—systemic scleroderma	0.000479	0.000904	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—systemic scleroderma	0.000479	0.000904	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—CSK—systemic scleroderma	0.000476	0.00242	CbGpPWpGaD
Pentosan Polysulfate—Infection—Prednisone—systemic scleroderma	0.000476	0.000898	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CSK—systemic scleroderma	0.000467	0.00237	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000882	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000463	0.000874	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IRF5—systemic scleroderma	0.00046	0.00233	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Prednisone—systemic scleroderma	0.000456	0.000862	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000455	0.000859	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—systemic scleroderma	0.000453	0.000856	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000452	0.0023	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000848	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—HSPG2—systemic scleroderma	0.000447	0.00227	CbGpPWpGaD
Pentosan Polysulfate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000841	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00084	CcSEcCtD
Pentosan Polysulfate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000442	0.000836	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—systemic scleroderma	0.000442	0.000835	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—ITGAM—systemic scleroderma	0.000439	0.00223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IRF8—systemic scleroderma	0.000439	0.00223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD247—systemic scleroderma	0.000439	0.00223	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Methotrexate—systemic scleroderma	0.000439	0.000829	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.000439	0.00223	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000436	0.000824	CcSEcCtD
Pentosan Polysulfate—Insomnia—Prednisone—systemic scleroderma	0.000433	0.000818	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-DQB1—systemic scleroderma	0.000432	0.00219	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CSK—systemic scleroderma	0.000431	0.00219	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Prednisone—systemic scleroderma	0.00043	0.000812	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—SMAD7—systemic scleroderma	0.000429	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD40LG—systemic scleroderma	0.000427	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CSK—systemic scleroderma	0.000426	0.00216	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Prednisone—systemic scleroderma	0.000421	0.000796	CcSEcCtD
Pentosan Polysulfate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00042	0.000792	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—IRF5—systemic scleroderma	0.000419	0.00213	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Methotrexate—systemic scleroderma	0.000417	0.000788	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—systemic scleroderma	0.000417	0.000788	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Prednisone—systemic scleroderma	0.000416	0.000786	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—systemic scleroderma	0.000412	0.000779	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000412	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TNFAIP3—systemic scleroderma	0.000411	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL1A—systemic scleroderma	0.00041	0.00208	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Prednisone—systemic scleroderma	0.000409	0.000773	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD40LG—systemic scleroderma	0.000408	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HSPG2—systemic scleroderma	0.000407	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BLK—systemic scleroderma	0.000406	0.00206	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD247—systemic scleroderma	0.000405	0.00206	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ITGAM—systemic scleroderma	0.000401	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IRF8—systemic scleroderma	0.000401	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD247—systemic scleroderma	0.000401	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.0004	0.00203	CbGpPWpGaD
Pentosan Polysulfate—Infection—Methotrexate—systemic scleroderma	0.000398	0.000751	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Prednisone—systemic scleroderma	0.000395	0.000745	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—CSK—systemic scleroderma	0.000393	0.002	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000392	0.00074	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000391	0.000739	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—SMAD7—systemic scleroderma	0.000391	0.00199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD40LG—systemic scleroderma	0.000389	0.00198	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000387	0.00073	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—systemic scleroderma	0.000381	0.00072	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisone—systemic scleroderma	0.00038	0.000718	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Prednisone—systemic scleroderma	0.000378	0.000715	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—TNFAIP3—systemic scleroderma	0.000375	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP9—systemic scleroderma	0.000375	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BLK—systemic scleroderma	0.000371	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD247—systemic scleroderma	0.00037	0.00188	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000365	0.000688	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—systemic scleroderma	0.000362	0.000683	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—systemic scleroderma	0.000359	0.000678	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—systemic scleroderma	0.000357	0.000674	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Prednisone—systemic scleroderma	0.000353	0.000666	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—systemic scleroderma	0.000352	0.000665	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—systemic scleroderma	0.000348	0.000657	CcSEcCtD
Pentosan Polysulfate—Pruritus—Prednisone—systemic scleroderma	0.000339	0.00064	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CTLA4—systemic scleroderma	0.000333	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RHOB—systemic scleroderma	0.000332	0.00168	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—systemic scleroderma	0.00033	0.000623	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Prednisone—systemic scleroderma	0.000328	0.000619	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000327	0.000618	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—systemic scleroderma	0.000318	0.0006	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisone—systemic scleroderma	0.000317	0.000598	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—systemic scleroderma	0.000316	0.000597	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—HSPG2—systemic scleroderma	0.000313	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—TGFB1—systemic scleroderma	0.000309	0.00157	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Prednisone—systemic scleroderma	0.000304	0.000575	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—CTLA4—systemic scleroderma	0.000304	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RHOB—systemic scleroderma	0.000302	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CSK—systemic scleroderma	0.000302	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP2—systemic scleroderma	0.000302	0.00153	CbGpPWpGaD
Pentosan Polysulfate—Rash—Prednisone—systemic scleroderma	0.000302	0.00057	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—systemic scleroderma	0.000302	0.000569	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisone—systemic scleroderma	0.0003	0.000566	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000295	0.000557	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—HSPG2—systemic scleroderma	0.000285	0.00145	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Prednisone—systemic scleroderma	0.000284	0.000537	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—systemic scleroderma	0.000283	0.000535	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSK—systemic scleroderma	0.000275	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-DQB1—systemic scleroderma	0.000274	0.00139	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Methotrexate—systemic scleroderma	0.000274	0.000517	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—EDN1—systemic scleroderma	0.000267	0.00135	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Methotrexate—systemic scleroderma	0.000265	0.0005	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IL1A—systemic scleroderma	0.00026	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD40LG—systemic scleroderma	0.000259	0.00131	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Methotrexate—systemic scleroderma	0.000254	0.00048	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—systemic scleroderma	0.000252	0.000476	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—systemic scleroderma	0.000252	0.000476	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—systemic scleroderma	0.000251	0.000473	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—HLA-DQB1—systemic scleroderma	0.00025	0.00127	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—systemic scleroderma	0.000238	0.000449	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—IL1A—systemic scleroderma	0.000237	0.00121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD40LG—systemic scleroderma	0.000236	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS3—systemic scleroderma	0.000232	0.00118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—systemic scleroderma	0.000227	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL1B—systemic scleroderma	0.000214	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—systemic scleroderma	0.000187	0.00095	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—systemic scleroderma	0.000182	0.000926	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDN1—systemic scleroderma	0.000169	0.00086	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—systemic scleroderma	0.000163	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—systemic scleroderma	0.000154	0.000784	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—systemic scleroderma	0.000153	0.000779	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—systemic scleroderma	0.000147	0.000748	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—systemic scleroderma	0.000136	0.00069	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—systemic scleroderma	0.000134	0.000682	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—systemic scleroderma	0.00013	0.000662	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—systemic scleroderma	0.000124	0.000629	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—systemic scleroderma	0.000116	0.000588	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—systemic scleroderma	0.000107	0.000546	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—systemic scleroderma	0.000106	0.000536	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—systemic scleroderma	0.000103	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—systemic scleroderma	9.74e-05	0.000495	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—systemic scleroderma	9.41e-05	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—systemic scleroderma	8.88e-05	0.000451	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—systemic scleroderma	8.28e-05	0.00042	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—systemic scleroderma	7.55e-05	0.000383	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—systemic scleroderma	6.82e-05	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—systemic scleroderma	6.22e-05	0.000316	CbGpPWpGaD
